PST0 Stock Chart & Stats
€4.38
€0.00(0.00%)
At close: 4:00 PM EST
€4.38
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€3.28 - €17.40
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€118.64M
Enterprise Value€888.87M
Total Cash (Recent Filing)€134.60M
Total Debt (Recent Filing)€765.50M
Price to Earnings (P/E)―
Beta1.85
Next Earnings
Aug 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.25
Shares Outstanding13,641,866
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)-0.26
Price to Sales (P/S)0.05
P/FCF Ratio0.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Free Cash Flow StrengthSustained TTM OCF (~$206M) and FCF (~$175M) provide durable internal funding to service interest, support working capital and fund capex. For a highly leveraged firm, ongoing strong cash conversion materially reduces refinancing pressure and improves operational resilience over the next 2–6 months.
Infrastructure Backlog And ScaleNear‑record DBMG backlog (~$1.6B reported / $1.8B adjusted) and strong Infrastructure revenue growth signal durable demand and multi‑period revenue visibility. The scale of the business supports repeatable project flow and operational leverage, making core earnings less cyclical over a medium horizon.
Improving Adjusted EBITDAA meaningful jump in adjusted EBITDA reflects improving cost structure and execution in core segments. Higher EBITDA margins, if sustained, translate to stronger cash generation and greater ability to narrow net losses, enhancing the company's capacity to de‑risk its balance sheet over several quarters.
Bears Say
Very High Leverage Vs. Thin EquityExtremely high debt relative to minimal equity leaves the company exposed to refinancing and covenant risk. Limited balance‑sheet flexibility constrains strategic choices, increases downside on earnings volatility, and elevates the probability that future cash needs require dilutive or costly financing.
Persistent Net Losses And Thin MarginsOngoing net losses and razor‑thin EBITDA margins provide little cushion against cost inflation or project underperformance. Even with revenue growth, limited margin expansion leaves earnings and free cash flow vulnerable, forcing continued reliance on operational improvement or external capital to achieve durable profitability.
Life Sciences Segment Weakness & Capital NeedA steep decline in Life Sciences revenue and explicit need for external capital create ongoing funding and execution risk. Smaller subsegments that require cash infusions can divert corporate liquidity, complicate capital allocation, and pressure consolidated results if they fail to scale as planned.
INNOVATE Corp News
PST0 FAQ
What was INNOVATE Corp’s price range in the past 12 months?
INNOVATE Corp lowest stock price was €3.28 and its highest was €17.40 in the past 12 months.
What is INNOVATE Corp’s market cap?
INNOVATE Corp’s market cap is €118.64M.
When is INNOVATE Corp’s upcoming earnings report date?
INNOVATE Corp’s upcoming earnings report date is Aug 12, 2026 which is in 31 days.
How were INNOVATE Corp’s earnings last quarter?
INNOVATE Corp released its earnings results on May 14, 2026. The company reported -€1.129 earnings per share for the quarter, missing the consensus estimate of N/A by -€1.129.
Is INNOVATE Corp overvalued?
According to Wall Street analysts INNOVATE Corp’s price is currently Overvalued.
Does INNOVATE Corp pay dividends?
INNOVATE Corp does not currently pay dividends.
What is INNOVATE Corp’s EPS estimate?
INNOVATE Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does INNOVATE Corp have?
INNOVATE Corp has 13,641,866 shares outstanding.
What happened to INNOVATE Corp’s price movement after its last earnings report?
INNOVATE Corp reported an EPS of -€1.129 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1%.
Which hedge fund is a major shareholder of INNOVATE Corp?
Currently, no hedge funds are holding shares in DE:PST0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
INNOVATE Corp Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Neutral
DE:PST0 Sentiment 50%
Sector Average 64%
Sector Average 64%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-3.83%
12-Months-Change
Fundamentals
Return on Equity
22.84%
Trailing 12-Months
Asset Growth
7.93%
Trailing 12-Months
Company Description
INNOVATE Corp
INNOVATE Corp. (VATE), a New York-based entity founded in 1994 and previously known as HC2 Holdings, Inc. until its name change in September 2021, manages a diverse range of subsidiaries operating within the infrastructure, life sciences, and spectrum sectors across the United States. Its extensive infrastructure division delivers services such as industrial construction, structural steel work, and facility maintenance. These capabilities are applied to a wide array of projects, including commercial structures like office complexes, hotels, casinos, convention centers, sports arenas, shopping malls, and hospitals, as well as significant industrial and civic infrastructure like dams, bridges, mines, metal processing plants, refineries, pulp and paper mills, and power generation facilities. INNOVATE also manufactures specialized components such as trusses, girders, water pipes, storage tanks, tunnel liners, pressure vessels, strainers, filters, separators, and other custom products. The company additionally offers integrated solutions encompassing digital engineering, modeling, detailing, construction, heavy equipment installation, and facility services, alongside expert steel and rebar detailing and BIM modeling and management. Furthermore, it supplies equipment critical to the oil, gas, petrochemical, and pipeline industries. Within the life sciences realm, INNOVATE focuses on the development of products designed to address early osteoarthritis of the knee, as well as aesthetic and medical technologies for skin care. Finally, its spectrum operations include the management of various over-the-air broadcasting stations and the operation of Azteca America, a Spanish-language broadcast network.
PST0 Company Deck
PST0 Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call reflects a predominantly positive operational story driven by a strong Infrastructure / DBMG performance that delivered outsized revenue (up 33% consolidated) and adjusted EBITDA improvement. Significant regulatory and clinical milestones at MediBeacon and international growth at R2 are constructive. However, meaningful challenges remain in smaller but important areas: Life Sciences revenues fell sharply (-48.4%), R2 is seeking external capital, Spectrum experienced advertising weakness and cancellations, DBMG saw ~140 bps gross margin compression, and consolidated debt increased due to PIK interest. Overall, the positive momentum in the company’s largest revenue driver and improved overall profitability outweighs the segment‑level headwinds, but capital structure and segment weaknesses warrant continued attention.View all DE:PST0 earnings summariesTechnical Analysis
1 Day
3 Days
1 Week
1 Month
SUNation Energy
―
Energy Services of America
―
Shimmick Corporation
―
SKK Holdings Limited
―
Ming Shing Group Holdings Limited
―
Options Prices
Currently, No data available
---







